¼¼°èÀÇ ÀÏȸ¿ë ¼Ò¸ðǰ ½ÃÀå
Single-Use Consumables
»óǰÄÚµå : 1792843
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 395 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀÏȸ¿ë ¼Ò¸ðǰ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 33¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 26¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÏȸ¿ë ¼Ò¸ðǰ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 4.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 33¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÀÏȸ¿ë Æ©ºùÀº CAGR 5.3%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 9¾ï 9,780¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÏȸ¿ë Ä¿³ØÅÍ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 7¾ï 130¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÏȸ¿ë ¼Ò¸ðǰ ½ÃÀåÀº 2024³â¿¡ 7¾ï 130¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 8.1%·Î 2030³â±îÁö 6¾ï 8,920¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.8%¿Í 3.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀÏȸ¿ë ¼Ò¸ðǰ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÏȸ¿ë ¼Ò¸ðǰÀÌ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º¿Í ÀÓ»ó ¿öÅ©Ç÷ο츦 À籸¼ºÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÀÏȸ¿ë ¼Ò¸ðǰÀº ±âÁ¸ÀÇ ½ºÅ×Àθ®½º ½ºÆ¿ ¹× Àç»ç¿ë °¡´ÉÇÑ ½Ã½ºÅÛÀ» ´ëüÇÒ ¼ö ÀÖ´Â È®Àå °¡´ÉÇÏ°í ¿À¿°ÀÌ ¾øÀ¸¸ç ºñ¿ë È¿À²ÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÔÀ¸·Î½á ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶, Áø´Ü ¹× ÀÓ»ó ¿öÅ©Ç÷ο츦 ºü¸£°Ô º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ¸ê±Õ Æ©ºê, ¹é, Ä¿³ØÅÍ, ÇÊÅÍ, ¹Í¼­, ¹ÙÀÌ¿À¸®¾×ÅÍ¿Í °°Àº ÀÏȸ¿ë ºÎǰÀº ¸ê±Õ, ¼¼Ã´ °ËÁõ, ±³Â÷ ¿À¿° Á¦¾îÀÇ Çʿ伺À» ¾ø¾Ö°í 1ȸ¿ëÀ¸·Î¸¸ »ç¿ëÇϵµ·Ï Ưº°È÷ ¼³°èµÇ¾ú½À´Ï´Ù. ¾÷½ºÆ®¸² ¹× ´Ù¿î½ºÆ®¸² ¹ÙÀÌ¿À °øÁ¤¿¡¼­ ´ÜÀÏ »ç¿ë ½Ã½ºÅÛ(SUS)Àº ÀüÀÓ»ó, ÀÓ»ó ¹× »ó¾÷ »ý»êÀÇ °¢ ´Ü°è¿¡¼­ ƯÈ÷ ´ÜŬ·ÐÇ×ü(mAbs), ¹é½Å, À¯ÀüÀÚ Ä¡·á ¹× ÀçÁ¶ÇÕ ´Ü¹éÁú¿¡ ´ëÇØ ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù. ƯÈ÷ ´ÙǰÁ¾ »ý»ê ȯ°æ¿¡¼­ Ç÷¯±× ¾Ø Ç÷¹ÀÌ ¸ðµâ¼ºÀ» ÅëÇØ ½Å¼ÓÇÑ ¹èÄ¡ Àüȯ, ¹ÎøÇÑ ¼³ºñ ¼³°è, Ä¡·áÁ¦ÀÇ ½ÃÀå Ãâ½Ã ½Ã°£À» ´ÜÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

³ôÀº Á¦Ç° ¼øµµ, ¼Ò·® ¹èÄ¡, À¯¿¬ÇÑ °øÁ¤ ±¸¼ºÀ» ÇÊ¿ä·Î ÇÏ´Â ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ÆÄÀÌÇÁ¶óÀÎÀÇ Áõ°¡´Â ÀÏȸ¿ë Ç÷§ÆûÀ¸·ÎÀÇ ÀüȯÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ¼Ò¸ðǰÀº ȯÀÚº° Àç·á¿Í ºü¸¥ 󸮷®ÀÌ ¿ä±¸µÇ´Â ÀÚ°¡ ¹× µ¿Á¾ ¿ä¹ý ¿öÅ©Ç÷ο쿡¼­ ¹«±Õ °æ°è¸¦ À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀ̸ç, ¾ö°ÝÇÑ ¿À¿° °ü¸®°¡ ¿ä±¸µË´Ï´Ù. ¶ÇÇÑ, ÀÓ»ó ½ÇÇè½Ç ¹× Áø´Ü ½Ã¼³¿¡¼­ ÇÇÆê ÆÁ, ¸¶ÀÌÅ©·ÎÇ÷¹ÀÌÆ®, ¹ÝÀÀ ¿ë±â, PCR Æ©ºê¿Í °°Àº ÀÏȸ¿ë ÇÃ¶ó½ºÆ½ Á¦Ç°Àº ½Ã·áÀÇ ÀÌ¿ùÀ» ¹æÁöÇÏ°í °Ë»ç °á°úÀÇ Ãæ½Çµµ¸¦ º¸ÀåÇϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ò¸ðǰÀº ÀÚµ¿ ¾×ü Ãë±Þ Ç÷§Æû¿¡ ¸Â°Ô ¸ÂÃãÈ­µÇ¾î ½ÇÇè½ÇÀÇ È¿À²¼º°ú 󸮷®À» ´õ¿í Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á, ÇöÀå Áø´Ü, Áö¼ÓÀûÀÎ ¹ÙÀÌ¿À Á¦Á¶°¡ ºÎ»óÇÔ¿¡ µû¶ó ÀÏȸ¿ë ¼Ò¸ðǰÀÇ °ü·Ã¼ºÀº °è¼Ó È®´ëµÇ°í ÀÖ½À´Ï´Ù.

Àç·á °úÇаú Á¦Á¶ Çõ½ÅÀº ¾î¶»°Ô ¼º´ÉÀ» Çâ»ó½Ã۰í Àִ°¡?

ÀÏȸ¿ë ¼Ò¸ðǰÀÇ ÁøÈ­´Â °íºÐÀÚ È­ÇÐ, ¾ÐÃâ ±â¼ú, Á¦Á¶ Á¤¹ÐµµÀÇ ¹ßÀü°ú ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖ½À´Ï´Ù. Æú¸®¿¡Æ¿·»(PE), Æú¸®ÇÁ·ÎÇÊ·»(PP), Æú¸®¿°È­ºñ´Ò(PVC), ¿¡Æ¿·»ºñ´Ò¾Æ¼¼Å×ÀÌÆ®(EVA), ºÒ¼Ò¼öÁö µî °í¼º´É ¿­°¡¼Ò¼º ÇÃ¶ó½ºÆ½Àº ¹«±Õ 󸮿¡ ÀûÇÕÇÑ °ß°íÇÏ°í »ýüÀûÇÕ¼ºÀÌ ³ôÀ¸¸ç ÃßÃ⼺ÀÌ ³·Àº ºÎǰÀ» Á¦Á¶ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. °ø±Þ¾÷ü´Â ÀúħÃ⼺ ÇÁ·ÎÆÄÀÏ, °¨¸¶ ¾ÈÁ¤¼º Àç·á, ±â°èÀû ³»±¸¼º, »ê¼Ò Åõ°ú¼º Á¦¾î, À庮 º¸È£ ±â´ÉÀ» Á¦°øÇÏ´Â ´ÙÃþ Çʸ§ °³¹ß¿¡ Á¡Á¡ ´õ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â »ý¹°ÇÐÀû Ȱ¼ºÀ» À¯ÁöÇϱâ À§ÇØ Á¦Ç°°ú ¿ë±â Àç·á¿ÍÀÇ »óÈ£ÀÛ¿ëÀ» ÃÖ¼ÒÈ­ÇØ¾ß ÇÏ´Â »ý¹°ÇÐÀû Á¦Á¦ Á¦Á¶¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù.

ÀûÃþ °¡°ø(3D ÇÁ¸°ÆÃ)°ú »çÃâ ¼ºÇü ±â¼úÀ» ÅëÇØ º¸´Ù ¾ö°ÝÇÑ °øÂ÷¿Í ÀϰüµÈ º® µÎ²²¸¦ °¡Áø º¹ÀâÇÑ Çü»óÀ» Á¦Á¶ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ¸ê±Õ È¥ÇÕ ½Ã½ºÅÛ, ¹é ¸Å´ÏÆúµå, ¿©°ú ¸ðµâ µî ¼öÀÛ¾÷À¸·Î ÀÎÇÑ Ãë±Þ ¹× Á¶ÀÛ ¿À·ù¸¦ ÁÙÀÌ´Â ÅëÇÕ ÀÏȸ¿ë ¾î¼Àºí¸®¸¦ °³¹ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. º¥´õ´Â ISO Ŭ·¡½º 5-8 Ç¥ÁØ ÀÎÁõÀ» ¹ÞÀº Ŭ¸°·ë Á¦Á¶ ½Ã¼³¿¡ ÅõÀÚÇÏ¿© ÀÏȸ¿ë ¼Ò¸ðǰÀÌ ±ÔÁ¦ ȯ°æ¿¡¼­ »ç¿ëµÇ´Â GMP ¹× USP Ŭ·¡½º VI¸¦ ÁؼöÇϵµ·Ï º¸ÀåÇÕ´Ï´Ù. °¨¸¶¼± Á¶»ç ¹× ÀüÀÚºö ¸ê±ÕÀ» ÅëÇÑ ¹«±Õ¼º º¸ÀåÀº Æó¼â ·çÇÁ Æ÷Àå ½Ã½ºÅÛ ¹× ½Ç½Ã°£ ·ÎÆ® ÃßÀûÀ¸·Î °­È­µÇ¾î ÃßÀû¼ºÀ» Çâ»ó½ÃŰ°í ¹Ì»ý¹° Ä§ÇØÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ Æ®·»µå´Â ÀÏȸ¿ë ¹ÙÀÌ¿À¸®¾×ÅÍ ¹éÀ̳ª Æ©ºê ¼¼Æ®¿¡ ³»ÀåµÈ ÀÏȸ¿ë ¼¾¼­ ¹× ¸ð´ÏÅ͸µ ±â±âÀÇ ÃâÇöÀÔ´Ï´Ù. ¿©±â¿¡´Â pH, ¿ëÁ¸»ê¼Ò(DO), ¾Ð·Â, ¿Âµµ¿ë ±¤ÇÐ ¼¾¼­°¡ Æ÷ÇԵǾî ÀÖ¾î ¹«±Õ °æ°è¸¦ ±úÁö ¾Ê°í ÀζóÀÎÀ¸·Î °øÁ¤ Á¦¾î°¡ °¡´ÉÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº °øÁ¤ ºÐ¼® ±â¼ú(PAT) ¹× ¼³°è¿¡ ÀÇÇÑ Ç°Áú °ü¸®(QbD) ¿øÄ¢¿¡ ºÎÇÕÇϸç, Á¦Á¶¾÷ü°¡ ½Ç½Ã°£ ¸±¸®½º¸¦ ´Þ¼ºÇÏ°í °øÁ¤ÀÇ °ß°í¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ±â¼úÀÌ ´õ¿í ÅëÇյǰí Áö´ÉÈ­µÊ¿¡ µû¶ó ¼öµ¿ÀûÀÎ ¿ë±â¿¡¼­ Æó¼âÇü ¹ÙÀÌ¿À Á¦Á¶ »ýŰèÀÇ ´Éµ¿ÀûÀÎ ±¸¼º¿ä¼Ò·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù.

¼¼°è ½ÃÀå¿¡¼­ µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ´Â ÃÖÁ¾ »ç¿ë ºÎ¹®Àº?

ÀÏȸ¿ë ¼Ò¸ðǰ¿¡ ´ëÇÑ °¡Àå °­·ÂÇÑ ¼ö¿ä´Â ¹ÙÀÌ¿À Á¦¾à ºÎ¹®, ƯÈ÷ CDMO(ÀǾàǰ °³¹ß ¹× Á¦Á¶ À§Å¹±â°ü)¿Í ½Å»ý ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷¿¡¼­ ¹ß»ýÇÕ´Ï´Ù. ÀÌµé ±â¾÷Àº ´ë±Ô¸ð ¼³ºñ °³Á¶ ¾øÀ̵µ ½ÇÇè½Ç¿¡¼­ »ó¾÷Àû ±Ô¸ð·Î ÇÁ·Î¼¼½º¸¦ È®ÀåÇÒ ¼ö ÀÖ´Â ÀÏȸ¿ëÀ» ¼±È£ÇÕ´Ï´Ù. ÀÏȸ¿ë ¹ÙÀÌ¿À¸®¾×ÅÍ, ¹Í½Ì¹é, ¿©°ú Ä«¼¼Æ®´Â mRNA ¹é½Å Á¦Á¶, ¹ÙÀÌ·¯½º º¤ÅÍ Á¦Á¶, ¼¼Æ÷ äÃë °øÁ¤¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ °¢ ±â¾÷µéÀÌ »ý»ê´É·Â È®´ë¸¦ ¼­µÎ¸£¸é¼­ ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ ÁõÆøµÇ¾úÁö¸¸, Àü ¼¼°è ¹é½Å ¹× »ý¹°ÇÐÀû Á¦Á¦ ÆÄÀÌÇÁ¶óÀÎÀÌ È°¹ßÇÏ°Ô ÁøÇàµÇ°í Àֱ⠶§¹®¿¡ ÀÌ·¯ÇÑ Ãß¼¼´Â °è¼ÓµÇ°í ÀÖ½À´Ï´Ù.

Áø´Ü ½ÇÇè½Ç, ƯÈ÷ ºÐÀÚÁø´Ü, Ç÷ûÇÐ °Ë»ç, ¹Ì»ý¹°ÇÐÀû ºÐ¼®À» ¼öÇàÇÏ´Â ½ÇÇè½ÇÀº ¶Ç ´Ù¸¥ ÁÖ¿ä ÃÖÁ¾ »ç¿ë ºÎ¹®ÀÔ´Ï´Ù. °¨¿°, À¯ÀüÀÚ ½ºÅ©¸®´×, ¾Ï Áø´ÜÀ» À§ÇÑ PCR °Ë»ç¸¦ ¼öÇàÇÏ´Â ÇÏÀ̽º·çDz ½ÇÇè½ÇÀº »ùÇà Á¶Á¦, ½Ã¾à ºÐÁÖ, ºÐ¼® ÆÇµ¶¿¡ ÀÏȸ¿ë ÇÃ¶ó½ºÆ½À» ¸¹ÀÌ »ç¿ëÇÕ´Ï´Ù. Ĩ ·¢, ¸®Àú¹ö, µöÀ£ Ç÷¹ÀÌÆ®, ¾Á¸µ Çʸ§ µî ÀÚµ¿È­ ´ëÀÀ ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô½À´Ï´Ù. ÇöÀå Áø·á ¹× ÀçÅà °Ë»çÀÇ ºÎ»óÀ¸·Î Áø´ÜÀÇ ºÐ»êÈ­°¡ °¡¼ÓÈ­µÇ´Â °¡¿îµ¥, ½Ã¾à°ú ´ëÁ¶¾àÀÌ ¹Ì¸® ä¿öÁø ÀÏȸ¿ë ŰƮ¿Í īƮ¸®Áö´Â ¼ÒºñÀÚ ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ ÇʼöÀûÀÎ ±¸¼º¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

ÀÇ·á ¹× ¼ö¼ú ºÐ¾ßµµ ¼ö¼ú½Ç°ú ÁßȯÀڽǿ¡¼­ »ç¿ëµÇ´Â ÀÏȸ¿ë ±â±¸, ü¾× °ü¸® ¼¼Æ®, ¹«±Õ À庮ÀÇ Áß¿äÇÑ ¼ÒºñÀÚÀÔ´Ï´Ù. ÀÇ·á °ü·Ã °¨¿°(HAI)°ú ±³Â÷ ¿À¿°¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö¸é¼­ º´¿øµéÀº ÀÏȸ¿ë Èĵΰæ, Ä«Å×ÅÍ, ¼ö¼ú¿ë ½ºÅ×ÀÌÇ÷¯·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC)³ª ÀÀ±Þ½Ç¿¡¼­´Â °ø°£ÀÇ Á¦¾à°ú ¸ê±Õ ÀÎÇÁ¶ó°¡ Á¦ÇÑÀûÀ̱⠶§¹®¿¡ ÀÏȸ¿ë Á¦Ç°À» ¼±È£Çϰí ÀÖ½À´Ï´Ù. ¼öÀÇÇÐ, Çмú ¿¬±¸, ½Äǰ °Ë»ç ½ÇÇè½ÇÀº ÀÛÁö¸¸ ¼ºÀåÇϰí ÀÖ´Â ÃÖÁ¾ »ç¿ë ºÐ¾ß·Î ÀÏȸ¿ë ¼Ò¸ðǰÀÇ ´Ù¾çÈ­¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ¹Ì·¡¸¦ Á¿ìÇÒ Àü·«Àû ¼ºÀå Ã˸ÅÁ¦´Â ¹«¾ùÀϱî?

¼¼°è ÀÏȸ¿ë ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀåÀº ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ºÀÇ Çõ½Å, ÇコÄɾîÀÇ µðÁöÅÐÈ­, ±ÔÁ¦ ´ç±¹ÀÇ ±â´ëÄ¡ÀÇ ÁøÈ­ µî ¿©·¯ °¡Áö ¿äÀÎÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. °¡Àå ¿µÇâ·Â ÀÖ´Â ÃËÁø¿äÀÎ Áß Çϳª´Â ¹ÙÀÌ¿À Á¦¾à »ê¾÷ÀÌ ¸ðµâ½Ä ´ÙǰÁ¾ »ý»ê ½Ã¼³·Î Àü·«ÀûÀ¸·Î ÀüȯÇϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¹ÎøÇÑ »ý»ê±âÁö´Â »ý»ê¶óÀÎÀÇ ½Å¼ÓÇÑ À籸¼º, ÀÚº»ÁöÃâ Àý°¨, ¿î¿µÀÇ À¯¿¬¼º Çâ»óÀ» À§ÇØ ÀÏȸ¿ë ½Ã½ºÅÛ¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. Ä¡·á¹ýÀÌ Æ´»õ ÀûÀÀÁõ°ú ȯÀÚ Áß½É Ã³¹æÀ¸·Î À̵¿ÇÔ¿¡ µû¶ó, ¹èÄ¡ Å©±â°¡ ÀÛ¾ÆÁö°í Àç»ç¿ë °¡´ÉÇÑ ½Ã½ºÅÛÀº °æÁ¦ÀûÀ¸·Î³ª ¿î¿µ»ó ºñÈ¿À²ÀûÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ¼Ò¸ðǰÀº ÀÌ·¯ÇÑ ½ºÄÉÀÏ ´Ù¿î ¹®Á¦¿¡ ´ëÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ ¼ºÀå ¿äÀÎÀº ºÐ»êÇü ÇコÄɾî¿Í ¸ÂÃãÇü Áø´ÜÀÇ ºÎ»óÀÔ´Ï´Ù. ÀçÅà °Ë»ç ŰƮ, ¿þ¾î·¯ºí ¹ÙÀÌ¿À¼¾¼­, ¸ð¹ÙÀÏ Å¬¸®´ÐÀº ¸ê±Õ ¹× °³ºÀ ¹æÁö Æ÷ÀåÀÇ ÄÄÆÑÆ®ÇÏ°í »ç¿ëÇϱ⠽¬¿î ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. FDA, EMA, WHO µî ±ÔÁ¦ ±â°üÀº ¿ëÃâ¹° °Ë»ç, ÃßÃâ¹° ÇÁ·ÎÆÄÀÏ, ÀÏȸ¿ë ½Ã½ºÅÛ °ËÁõ¿¡ ´ëÇÑ Ãֽа¡À̵å¶óÀÎÀ» ¹ßÇ¥ÇÏ¿© Ç¥ÁØÈ­¸¦ ÃËÁøÇϰí ÃÖÁ¾»ç¿ëÀÚÀÇ ½Å·Ú¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àç°í ÃßÀû, ¹ÙÄÚµå ½ºÄ³´×, RFID ű×ÀÇ µðÁöÅÐ ÅëÇÕÀ» ÅëÇØ °í󸮷® ÀÓ»ó ȯ°æ¿¡¼­ º¸´Ù ½º¸¶Æ®ÇÑ ¹°·ù¿Í Àç°í ¼ÒÁøÀ» ÁÙÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¼Ò¸ðǰ Á¦Á¶¾÷ü¿Í Á¦¾à, Áø´Ü, ÀÚµ¿È­ ±â¾÷°úÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀº Çõ½ÅÀÇ ÆÄÀÌÇÁ¶óÀÎÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. OEM°úÀÇ Á¦ÈÞ ¹× °øµ¿ °³¹ß °è¾àÀ» ÅëÇØ Çü»ó, Àç·á ¹èÇÕ, ºÐ¼® ±â´ÉÀÌ ³»ÀåµÈ ¿ëµµ¿¡ ƯȭµÈ ¼Ò¸ðǰÀÌ Åº»ýÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä«¸¦ Áß½ÉÀ¸·Î ÇÑ Áö¿ª Á¦Á¶ °ÅÁ¡¿¡ ´ëÇÑ ÅõÀÚ·Î ¸®µå ŸÀÓÀ» ´ÜÃàÇÏ°í º¸´Ù ½Å¼ÓÇÑ °ø±Þ¸ÁÀ» ½ÇÇöÇϰí ÀÖ½À´Ï´Ù. ¿ä¾àÇϸé, ÀÏȸ¿ë ¼Ò¸ðǰÀÇ ½ÃÀå Àü¸ÁÀº Á¦Á¶ ¸ðµ¨ÀÇ Àå±âÀûÀÎ º¯È­, °¨¿° °ü¸®ÀÇ ¿ì¼±¼øÀ§, µðÁöÅÐ ÀÇ·á ÀÎÇÁ¶ó¿¡ ÈûÀÔ¾î ¸Å¿ì ¹à½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(Æ©ºù, Ä¿³ØÅÍ, µð½ºÄ¿³ØÅÍ, ¾î´ðÅÍ, ¹ëºê, ÀÏȸ¿ë ĸ½¶ ÇÊÅÍ, ¼¾¼­), ¿ëµµ(¿©°ú ¿ëµµ, ¼¼Æ÷¹è¾ç¡¤È¥ÇÕ ¿ëµµ, º¸Á¸ ¿ëµµ, »ùÇøµ ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(¹ÙÀÌ¿ÀÀǾàǰ¡¤Á¦¾à ±â¾÷, OEM, ÀÓ»ó½ÃÇè¼öʱâ°ü¡¤À§Å¹»ý»ê, Çмú¡¤¿¬±¸±â°ü)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡°¡ ¼±º°ÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Single-Use Consumables Market to Reach US$3.3 Billion by 2030

The global market for Single-Use Consumables estimated at US$2.6 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Single Use Tubing, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$997.8 Million by the end of the analysis period. Growth in the Single Use Connectors segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$701.3 Million While China is Forecast to Grow at 8.1% CAGR

The Single-Use Consumables market in the U.S. is estimated at US$701.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$689.2 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Single-Use Consumables Market - Key Trends & Drivers Summarized

Why Are Single-Use Consumables Reshaping Bioprocessing and Clinical Workflows?

Single-use consumables are rapidly transforming biopharmaceutical manufacturing, diagnostics, and clinical workflows by offering scalable, contamination-free, and cost-efficient alternatives to traditional stainless-steel or reusable systems. These disposable components-including bags, tubing, connectors, filters, mixers, and bioreactors-are specifically engineered for one-time use, eliminating the need for sterilization, cleaning validation, and cross-contamination control. In upstream and downstream bioprocessing, single-use systems (SUS) have gained wide adoption across preclinical, clinical, and commercial production phases, especially for monoclonal antibodies (mAbs), vaccines, gene therapies, and recombinant proteins. Their plug-and-play modularity enables faster batch changeovers, agile facility design, and shorter time-to-market for therapeutics, particularly in multi-product manufacturing environments.

The rise in cell and gene therapy pipelines, which require high product purity, small batch volumes, and flexible process configurations, has further accelerated the shift toward disposable platforms. Single-use consumables are essential in maintaining sterile boundaries across autologous and allogeneic therapy workflows, where patient-specific materials and rapid throughput demand strict contamination controls. Additionally, in clinical labs and diagnostic facilities, single-use plasticware such as pipette tips, microplates, reaction vessels, and PCR tubes are critical for preventing sample carryover and ensuring test result fidelity. These consumables are increasingly customized for automated liquid handling platforms, further enhancing laboratory efficiency and throughput. As personalized medicine, point-of-care diagnostics, and continuous biomanufacturing gain ground, the relevance of single-use consumables continues to expand.

How Are Material Science and Manufacturing Innovations Enhancing Performance?

The evolution of single-use consumables is closely linked to advancements in polymer chemistry, extrusion technology, and manufacturing precision. High-performance thermoplastics like polyethylene (PE), polypropylene (PP), polyvinyl chloride (PVC), ethylene-vinyl acetate (EVA), and fluoropolymers are used to manufacture robust, biocompatible, and low-extractable components suitable for sterile processing. Suppliers are increasingly focused on developing low leachables profiles, gamma-stable materials, and multilayer films that offer mechanical durability, oxygen permeability control, and barrier protection. This is particularly crucial in biologics manufacturing, where interactions between product and container materials must be minimized to preserve biological activity.

Additive manufacturing (3D printing) and injection molding technologies are also enabling the production of complex geometries with tighter tolerances and consistent wall thickness. This has allowed the development of integrated single-use assemblies, such as pre-sterilized mixing systems, bag manifolds, and filtration modules that reduce manual handling and operational errors. Vendors are investing in cleanroom manufacturing facilities certified to ISO Class 5-8 standards, ensuring that single-use consumables meet GMP and USP Class VI compliance for use in regulated environments. Sterility assurance via gamma irradiation or electron beam sterilization is being enhanced by closed-loop packaging systems and real-time lot tracking to improve traceability and reduce the risk of microbial breaches.

Another key trend is the emergence of single-use sensors and monitoring devices embedded into disposable bioreactor bags and tubing sets. These include optical sensors for pH, dissolved oxygen (DO), pressure, and temperature, enabling in-line process control without breaching sterile boundaries. These innovations are aligning with the principles of Process Analytical Technology (PAT) and Quality by Design (QbD), helping manufacturers achieve real-time release and improve process robustness. As single-use technologies become more integrated and intelligent, they are shifting from passive containers to active components of closed-loop biomanufacturing ecosystems.

Which End-Use Segments Are Accelerating Adoption Across Global Markets?

The strongest demand for single-use consumables originates from the biopharmaceutical sector, particularly in contract development and manufacturing organizations (CDMOs) and emerging biotech firms. These players favor disposables due to their ability to scale processes from lab to commercial scale without extensive facility retrofitting. Single-use bioreactors, mixing bags, and filtration cassettes are widely used in mRNA vaccine manufacturing, viral vector production, and cell harvesting steps. The COVID-19 pandemic amplified demand for such systems as companies raced to expand capacity, and the trend continues as global vaccine and biologics pipelines remain active.

Diagnostic laboratories, particularly those performing molecular diagnostics, serological testing, and microbiology assays, are another major end-use segment. High-throughput labs conducting PCR testing for infectious diseases, genetic screening, and cancer diagnostics rely heavily on single-use plastics for sample preparation, reagent dispensing, and assay readout. Automation-compatible consumables such as tip racks, reservoirs, deep-well plates, and sealing films are in high demand. As diagnostic decentralization accelerates with the rise of point-of-care and home testing, single-use kits and cartridges pre-filled with reagents and controls are becoming essential components of consumer-facing healthcare solutions.

The medical and surgical field is also a significant consumer of disposable instruments, fluid management sets, and sterile barriers used in operating rooms and intensive care units. Growing concerns about healthcare-associated infections (HAIs) and cross-contamination have prompted hospitals to shift toward single-use laryngoscopes, catheters, and surgical staplers. In addition, ambulatory surgical centers (ASCs) and emergency clinics prefer single-use products due to space constraints and limited sterilization infrastructure. Veterinary medicine, academic research, and food testing laboratories represent smaller yet growing end-use verticals contributing to the diversification of single-use consumables.

What Are the Strategic Growth Catalysts Shaping the Future of This Market?

The growth in the global single-use consumables market is driven by several factors that underscore the convergence of bioprocess innovation, healthcare digitization, and evolving regulatory expectations. One of the most impactful drivers is the biopharma industry's strategic pivot toward modular, multi-product manufacturing facilities. These agile production sites depend heavily on single-use systems to quickly reconfigure production lines, reduce capital expenditure, and improve operational flexibility. As therapies move toward niche indications and patient-centric formulations, batch sizes are decreasing, making reusable systems economically and operationally inefficient. Single-use consumables provide a ready solution to this scale-down challenge.

Another key growth enabler is the rise of decentralized healthcare and personalized diagnostics. Home-based test kits, wearable biosensors, and mobile clinics are driving demand for compact, user-friendly consumables with pre-sterilized and tamper-proof packaging. Regulatory bodies including the FDA, EMA, and WHO are issuing updated guidelines on leachables testing, extractables profiles, and validation of single-use systems, encouraging standardization and enhancing end-user confidence. Furthermore, the digital integration of inventory tracking, barcode scanning, and RFID tagging is enabling smarter logistics and reduced stockouts in high-throughput clinical environments.

Strategic partnerships between consumables manufacturers and pharmaceutical, diagnostics, and automation companies are catalyzing innovation pipelines. OEM collaborations and co-development agreements are giving rise to application-specific consumables with tailored geometries, material formulations, and embedded analytics. Investment in regional manufacturing hubs, especially in Asia-Pacific and Latin America, is reducing lead times and enabling more responsive supply chains. In summary, the market outlook for single-use consumables is highly positive, underpinned by long-term shifts in manufacturing models, infection control priorities, and digital health infrastructure.

SCOPE OF STUDY:

The report analyzes the Single-Use Consumables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Single Use Tubing, Single Use Connectors, Single Use Disconnector, Single Use Adapters, Single Use Valves, Single Use Disposable Capsule Filter, Single Use Sensors); Application (Filtration Application, Cell Culture & Mixing Application, Storage Application, Sampling Application, Other Applications); End-Use (BioPharmaceuticals & Pharmaceuticals Companies End-Use, OEM End-Use, Contract Research Organizations & Contract Manufacturing Organizations End-Use, Academic & Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â